Table of Contents Table of Contents
Previous Page  E129 844 Next Page
Show Menu
Previous Page E129 844 Next Page
Page Background



Hall of Fame

European Urology would like to recognize the award-winning authors and exceptional reviewers who ensure

that ‘your’ platinum journal remains a cut above the rest.

Best Scientific Paper Prizes 2000 to the Present


Laparoscopic Radical Prostatectomy: Technical and

Early Oncological Assessment of 40 Operations

B. Guillonneau, X. Cathelineau, E. Barret, F. Rozet, G. Vallancien

European Urology 1999;36:14–20


RPLND or Primary Chemotherapy in Clinical Stage

IIA/B Nonseminomatous Germ Cell Tumors? Results

of a Prospective Multicenter Trial Including Quality of

Life Assessment

L. Weissbach, R. Bussar-Maatz, H. Flechtner, U. Pichlmeier,

M. Hartmann, L. Keller

European Urology 2000;37:582–594


Nonrandomized Comparison of Open Flank versus

Laparoscopic Nephrectomy in 249 Patients with Benign

Renal Disease

P. Fornara, C. Doehn, H.-J. Friedrich, D. Jocham

European Urology 2001;40:24–31


Laparoscopic Dismembered Pyeloplasty – The Method

of Choice in the Presence of an Enlarged Renal Pelvis

and Crossing Vessels

I.A. Türk, J.W. Davis, B. Winkelmann, S. Deger, F. Richter,

M.D. Fabrizio, B. Schönberger, G.H. Jordan, S.A. Loening

European Urology 2002;42:268–275


The Side Effects of Bacillus Calmette-Guérin in the

Treatment of Ta T1 Bladder Cancer do not Predict its

Efficacy: Results from a European Organisation for

Research and Treatment of Cancer Genito-Urinary

Group Phase III Trial

R.J. Sylvester, A.P.M. Van Der Meijden, W. Oosterlinck, W. Hoeltl,

A.V. Bono

European Urology 2003;44:423–428


Maintenance Bacillus Calmette-Guérin for Ta T1 Bladder

Tumors is not Associated with Increased Toxicity:

Results from a European Organisation for Research and

Treatment of Cancer Genito-Urinary Group Phase III Trial

A.P.M. Van Der Meijden, R.J. Sylvester, W. Oosterlinck, W. Hoeltl,

A.V. Bono

European Urology 2003;44:429–434




RNA Analysis in Urine – A New Perspective for

Detecting Prostate Cancer

M. Tinzl, M. Marberger, S. Horvath, C. Chypre

European Urology 2004;46:182–186


Prevalence of Asymptomatic Coronary Artery Disease

in Men with Vasculogenic Erectile Dysfunction:

A Prospective Angiographic Study

C. Vlachopoulos, K. Rokkas, N. Ioakeimidis, C. Aggeli, A. Michaelides,

G. Roussakis, C. Fassoulakis, A. Askitis, C. Stefanadis

European Urology 2005;48:996–1002


Excellent Long-Term Cancer Control with Elective

Nephron-Sparing Surgery for Selected Renal Cell

Carcinomas Measuring More Than 4 cm

F. Becker, S. Siemer, M. Hack, U. Humke, M. Ziegler, M. Stöckle

European Urology 2006;49:1058–1064


Elective Nephron-Sparing Surgery Should Become

Standard Treatment for Small Unilateral Renal Cell

Carcinoma: Long-term Survival Data of 216 Patients

F. Becker, S. Siemer, U. Humke, M. Hack, M. Ziegler, M. Stöckle

European Urology 2006;49:308–313


Morbidity and Clinical Outcome of Nephron-Sparing

Surgery in Relation to Tumour Size and Indication

J.-J. Patard, A.J. Pantuck, M. Crepel, J.S. Lam, L. Bellec, B. Albouy,


C. Pfister, M. Soulié, J. Tostain, J.-M. Ferriere, C.C. Abbou, M. Colombel,

A.S. Belldegrun

European Urology 2007;52:148–154


The Template of the Primary Lymphatic Landing

Sites of the Prostate Should Be Revisited: Results of a

Multimodality Mapping Study

A.Mattei, F.G.Fuechsel, N.BhattaDhar,S.H.Warncke,G.N.Thalmann,

T. Krause, U.E. Studer

European Urology 2008;53:118–125


Preoperative Aspects and Dimensions Used for an

Anatomical (PADUA) Classification of Renal Tumours

in Patients who are Candidates for Nephron-Sparing


V. Ficarra, G. Novara, S. Secco, V. Macchi, A. Porzionato, R. De Caro,

W. Artibani

European Urology 2009;56:786–793

Sponsored By Elsevier